高剂量与标准剂量流感疫苗接种后发生心肌炎或心包炎的风险：随机DANFLU-2试验的预先设定的二次分析 - Suppr | 超能文献

Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial.

作者信息

Pareek Manan, Johansen Niklas Dyrby, Modin Daniel, Loiacono Matthew M, Harris Rebecca C, Dufournet Marine, Larsen Carsten Schade, Larsen Lykke, Wiese Lothar, Dalager-Pedersen Michael, Claggett Brian L, Janstrup Kira Hyldekær, Bartholdy Katja Vu, Bernholm Katrine Feldballe, Borchsenius Julie Inge-Marie Helene, Davidovski Filip Søskov, Davodian Lise Witten, Dons Maria, Duus Lisa Steen, Espersen Caroline, Fussing Frederik Holme, Jensen Anne Marie Reimer, Landler Nino Emanuel, Langhoff Adam Cadovius Femerling, Lassen Mats Christian Højbjerg, Nielsen Anne Bjerg, Ottosen Camilla Ikast, Sengeløv Morten, Skaarup Kristoffer Grundtvig, Solomon Scott D, Landray Martin J, Gislason Gunnar H, Køber Lars, Sivapalan Pradeesh, Martel Cyril Jean-Marie, Jensen Jens Ulrik Stæhr, Biering-Sørensen Tor

机构信息

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.

Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

JAMA Netw Open. 2025 Aug 1;8(8):e2536889. doi: 10.1001/jamanetworkopen.2025.36889.

DOI:10.1001/jamanetworkopen.2025.36889

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12398704/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12398704/f15d36c04a23/jamanetwopen-e2536889-g001.jpg

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial.

JAMA Netw Open. 2025 Aug 1;8(8):e2536889. doi: 10.1001/jamanetworkopen.2025.36889.

2

High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.

JAMA Cardiol. 2025 Aug 30. doi: 10.1001/jamacardio.2025.3460.

3

A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.

Am Heart J. 2025 Jul 30. doi: 10.1016/j.ahj.2025.07.069.

4

High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial.

Circ Heart Fail. 2025 Aug 30. doi: 10.1161/CIRCHEARTFAILURE.125.013678.

5

High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.

Eur Heart J. 2025 Aug 30. doi: 10.1093/eurheartj/ehaf678.

6

Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trial.

J Infect Dis. 2025 Aug 13. doi: 10.1093/infdis/jiaf420.

7

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.

N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509907.

8

Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.

J Med Virol. 2024 Jun;96(6):e29693. doi: 10.1002/jmv.29693.

9

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.

PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.

10

Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources.

Vaccines (Basel). 2025 Jul 16;13(7):755. doi: 10.3390/vaccines13070755.

本文引用的文献

1

High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.

JAMA Cardiol. 2025 Aug 30. doi: 10.1001/jamacardio.2025.3460.

2

N Engl J Med. 2022 Oct 20;387(16):1488-1500. doi: 10.1056/NEJMra2114478.

3

A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination.

PLoS One. 2015 Mar 20;10(3):e0118283. doi: 10.1371/journal.pone.0118283. eCollection 2015.

4

Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

N Engl J Med. 2014 Aug 14;371(7):635-45. doi: 10.1056/NEJMoa1315727.

5

Cardiovascular manifestations associated with influenza virus infection.

Int J Cardiol. 2008 Nov 28;130(3):304-9. doi: 10.1016/j.ijcard.2008.04.044. Epub 2008 Jul 14.